Lawrence Berkeley National Laboratory masthead A-Z Index Berkeley Lab masthead U.S. Department of Energy logo Phone Book Jobs Search
Tech Transfer

Tech Transfer in the News

2009 News:

Berkeley Lab executed an exclusive license agreement with Novartis Vaccines and Diagnostics for patent-pending technology "SATB1: A Determinant of Morphogenesis and Tumor Metastasis." The SATB1 technology, developed by lead inventor Terumi Kohwi-Shigematsu in the Life Sciences Division at Berkeley Lab, showed that SATB1 protein can be down-regulated to prevent a tumor cell from becoming malignant, rendering it to be an effective prognostic and diagnostic marker for detecting aggressive cancer cells. Go here for a description of the technology.

More than $1 million in royalties was distributed to 119 scientists and authors at Berkeley Lab for inventions and software that was licensed to industry and publishers in 2008. The researchers received their checks at a special ceremony on Feb. 11. Among the technologies that received licensing were robotics for nanovolume protein crystallography, highly sensitive room temperature semiconductor radiation detectors, and energy efficient fume hoods. The licensing deals will bring approximately $2 million to the Lab to fund research and development. Read more here.

2008 News Stories

2007 News Stories

2006 News Stories (and older)

Last updated: 09/17/2009